top of page
Site Under Construction
Expansion Leadership
We believe that the development of small molecule drugs that modulate RNA will dramatically change patient outcomes for diseases where treatment options for patients are currently limited
RNA and the World of Small Molecules
Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases
We are a team in relentless pursuit of game changing solutions in human health
Our team's work is founded upon leading research emerging from Scripps Research
Our management team has deep experience in bringing life-changing drugs from bench to clinic and ultimately to market
Drug Hunters
Success Record
Inspired Research
Sai Velagapudi, PhD
Principal Scientist
Nicole DeLorenzo, BS
Associate Scientist
Michelle Arsenault, BS
Associate Scientist
Kamal Vishnu, MS
Scientist
Treleasha Simmons, BS
Research Associate II
Jason Ilardo
Research Associate II
Virginia Smith, PhD
Scientific Program Manager
Alicia Angelbello, PhD
Senior Scientist II
Helen Crehan, PhD
Principal Scientist
Van Ha, MS
Scientist
Jared Baisden, PhD
Senior Scientist I
Daniela Saldias, BS
Research Associate II
Sandra Mueller
Associate Director, Operations
Imelda Sollomoni, BS
Senior Scientist II
Aleta Cebere, PhD
Principal Scientist
.jpg)
Priah Nadarajan, PhD
Senior Scientist I
Jon Ainsley, PhD
Senior Scientist I, Computational Chemistry
Barnett Alfant, MS
Laboratory Manager
Romy Aiken, MS
Research Associate I
...and the many Expanding the vision to cure mRNA mediated diseases.
Board of Directors
Scientific Advisory Board
Matthew Disney, PhD
Scientific Founder, Scientific Advisory Board Chair,
Professor, UF Scripps Research
INVESTORS
bottom of page